Related Experiment Video
Updated: Sep 16, 2025
Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
Caffeinated chewing gum produces comparable strength and power gains to capsules with fewer side effects in
Background:
Caffeine, widely used as an ergogenic aid, has been extensively studied regarding its dosage and timing of ingestion. However, the impact of different administration methods on caffeine's performance-enhancing effects remains relatively underexplored. This study compared the effects of caffeine administered via chewing gum versus capsules on maximal strength, muscular power, and side effects during bench press and back squat exercises.
Methods:
Sixteen resistance-trained males participated in a double-blind, randomized trial, ingesting either a 4 mg/kg caffeine capsule (CC) or placebo capsule (PC) one hour before testing, or a 4 mg/kg caffeinated gum (CG) (4 mg/kg) or placebo gum (PG) five minutes prior. Assessments including one-repetition maximum (1RM) and muscular power at 25%, 50%, 75%, and 90%1RM for bench press and back squat.
Results:
Caffeine increased 1RM (+2.1-5.0%) and muscular power (+6.1-20.0%) in both the bench press and back squat compared to placebo (all p < 0.05). However, no significant differences were observed between CC and CG for maximal strength or muscular power (all p > 0.05). Furthermore, CG was associated with fewer reports of gastrointestinal discomfort (12.5% vs. 37.5%) immediately post-exercise and tachycardia/heart palpitations (0% vs. 25.0%) at 24 hours compared to CC (all p < 0.05).
Conclusion:
Caffeinated gum (4 mg/kg) produced ergogenic effects comparable to capsules in enhancing maximal strength and muscular power during bench press and back squat exercises, with fewer side effects in resistance-trained men.
Related Concept Videos
01:28Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
01:29Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
01:27Exercise and Muscle Performance
Endurance exercises
Endurance exercises involve running, swimming, or cycling, which require repetitive movements with low force output. When a person engages in endurance exercise, a few noticeable changes occur in their skeletal muscles. For instance, the number of capillaries...
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids